Table of Contents
Volume 4 | Issue 1
Publication Date: June 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
9 |
Minimal Residual Disease in Lymphoma Revisited Anton Hagenbeek |
|
Meeting Highlights | ||
10-15 |
From: 44th Annual Meeting of the American Society of Hematology, Philadelphia, Pennsylvania Heather DeGrendele, Angelia D. Gibson, Mary Hightower, Vinay K. Jain |
|
Research in Brief | ||
19-21 |
Factors Predicting the Response to Rituximab in Indolent Lymphoma David Lee, Vinay K. Jain, Peter McLaughlin |
|
Comprehensive Review | ||
22-29 |
Primary Ocular Lymphoma: Clinical Features, Diagnosis, and Treatment Adília Hormigo, Lisa M. DeAngelis |
|
Commentary | ||
30-31 |
Primary Intraocular Lymphoma: Clinical Features, Diagnosis, and Treatment Chi-Chao Chan |
|
Original Contributions | ||
32-35 |
Thalidomide and Deep Vein Thrombosis in Multiple Myeloma: Risk Factors and Effect on Survival Maurizio Zangari, Bart Barlogie, Raymond Thertulien, Joth Jacobson, Paul Eddleman, Louis Fink, Athanasios Fassas, Frits Van Rhee, Giampaolo Talamo, Choon-Kee Lee, Guido Tricot |
|
36-42 |
First-Line Treatment with Brief-Duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-Grade Non-Hodgkin’s Lymphoma: Phase II Trial John D. Hainsworth, Sharlene Litchy, M. Ray Lamb, Gladys I. Rodriguez, Carroll Scroggin, Jr., F. Anthony Greco |
|
Imaging in Lymphoma | ||
43-49 |
Frequent Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography on the Staging and Management of Patients with Indolent Non-Hodgkin’s Lymphoma Robert H. Blum, John F. Seymour, Andrew Wirth, Michael MacManus, Rodney J. Hicks |
|
Commentary | ||
50-51 |
Positron Emission Tomography in the Management of Patients with Indolent Non-Hodgkin’s Lymphoma Ralph Naumann, Bettina Beuthien-Baumann |
|
Brief Communication | ||
52-55 |
Prognostic Significance of the Immunophenotype Versus the International Prognostic Index in Aggressive Non-Hodgkin’s Lymphoma Tanin Intragumtornchai, Ponlapat Rotnakkarin, Pranee Sutcharitchan, Pongsak Wannagrairoj |
|
Case Report | ||
56-59 |
Use of Ibritumomab Tiuxetan Anti-CD20 Radioimmunotherapy in a Non-Hodgkin’s Lymphoma Patient Previously Treated with a Yttrium-90–Labeled Anti-CD22 Monoclonal Antibody Donald E. Tsai, Ivan Maillard, Stephen J. Schuster, Sunita D. Nasta, David L. Porter, Thomas R. Klumpp, David M. Goldenberg, Selina M. Luger, Abass Alavi, Robert M. Sharkey, Kenneth B. Hartzell, Edward A. Stadtmauer |
|